GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.
about
Traditional used Plants against Cognitive Decline and Alzheimer Disease.Effects of diet on brain plasticity in animal and human studies: mind the gap.Using genetics to enable studies on the prevention of Alzheimer's diseaseClinical data in early intervention.Effect of ginkgolide B on brain metabolism and tissue oxygenation in severe haemorrhagic strokeMechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics StrategiesPrevention strategies for Alzheimer's disease.Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia.The role of phytochemicals in the treatment and prevention of dementia.Medicinal plants and dementia therapy: herbal hopes for brain aging?Recruitment methods for United States Alzheimer disease prevention trials.Examining brain-cognition effects of ginkgo biloba extract: brain activation in the left temporal and left prefrontal cortex in an object working memory taskGinkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.The potential and limits for clinical trials for early Alzheimer's disease and some recommendations.Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1.Ginkgolide B reduces neuronal cell apoptosis in the traumatic rat brain: possible involvement of toll-like receptor 4 and nuclear factor kappa B pathway.Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
P2860
Q30474547-F03CA326-A070-4B0F-A5A2-6D0B4A61E1BCQ33679165-3F020DA0-58FB-45BA-9319-A2982408C215Q34038890-5BCFB36D-E8D2-4AE4-8BC6-652C35F6E8C0Q34333371-77FE0906-6C31-46BC-8AC6-0F150696BA8FQ35643583-FDBFA6A2-2882-45D2-83A4-3348910F8FFCQ35752353-46F6004D-8D16-4E16-B86C-E207BF4AD791Q36444462-903743DF-6CAF-4F45-85DB-1B10DE547AB3Q37436616-F64C579B-851C-4229-8592-0EE421CC1D3BQ37884566-88421098-3E7A-472F-95E4-12A49C1901C4Q37954368-60958BF2-7507-4110-A766-886C1CBAC60FQ38002365-E15B22EA-60F9-484C-B3E0-31B7472E7926Q38299487-ACC07883-1428-4E0D-BA94-DD97DF3E8142Q41600619-A1F83379-CC00-45DA-8869-C9254D95C64DQ41847327-479EE335-E38C-4879-9A92-9E6BAC7F8DE2Q47372291-4E61F7E2-399F-473D-A867-B726E3D0CBBAQ47851394-751E4A1F-FB64-4FC1-A342-401A51BBC3D3Q48612880-314DD305-0C5E-4B34-BC78-23A2C19277D4Q52644591-BFEF14B1-1CFA-443A-A4F9-6337190FB010
P2860
GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
GuidAge study: a 5-year double ...... ale, design and baseline data.
@ast
GuidAge study: a 5-year double ...... ale, design and baseline data.
@en
type
label
GuidAge study: a 5-year double ...... ale, design and baseline data.
@ast
GuidAge study: a 5-year double ...... ale, design and baseline data.
@en
prefLabel
GuidAge study: a 5-year double ...... ale, design and baseline data.
@ast
GuidAge study: a 5-year double ...... ale, design and baseline data.
@en
P2093
P1476
GuidAge study: a 5-year double ...... ale, design and baseline data.
@en
P2093
GuidAge study GROUP
Hélène Mathiex-Fortunet
Mehemed Ouzid
Nicola Coley
Pierre-Jean Ousset
Sandrine Andrieu
P304
P356
10.2174/156720508785132271
P50
P577
2008-08-01T00:00:00Z